Search

everythinglearnresearchcommunity

for

Search:↓

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

People with alopecia areata often have lower vitamin D levels than healthy people.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

A nurse-led hair service reduced waiting times and improved patient satisfaction and outcomes for alopecia areata treatment.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Alefacept does not effectively treat severe alopecia areata.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Tofacitinib effectively treats Alopecia Areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.